The National MS Society and the National Institutes of Health (NINDS) are funding a team of investigators at sixteen medical centers across the U.S. to conduct a two-year, placebo-controlled clinical trial testing treatment with the estrogen of pregnancy (estriol) in MS.

All 150 women with relapsing-remitting MS will take CopaxoneŽ (glatiramer acetate, Teva Pharmaceutical Industries Ltd.) in combination with either oral estriol or oral placebo. Patients previously treated with an interferon or CopaxoneŽ may be included.

The estriol trial is taking place at sixteen medical centers across the U.S. Women between 18-50 who are diagnosed with relapsing remitting MS and are interested in participating in this clinical trial should contact the nearest site to discuss their eligibility:

Contact: For more information, contact the study at the sites on
(NCT00451204) on ClinicalTrials.gov.

Copaxone would be free for two years. If that helps anyone who wants to be one it.

I found it, the Clicical trial site.
http://clinicaltrials.gov./ct2/results?term=NCT00451204

or the where the MS centers are listed.
http://clinicaltrials.gov./ct2/show/...0451204&rank=1


.